Market revenue in 2023 | USD 517.3 million |
Market revenue in 2030 | USD 1,787.4 million |
Growth rate | 19.4% (CAGR from 2023 to 2030) |
Largest segment | Pcr technology |
Fastest growing segment | NGS Technology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies |
Key market players worldwide | Basf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synthetic biology market will help companies and investors design strategic landscapes.
Pcr technology was the largest segment with a revenue share of 27.49% in 2023. Horizon Databook has segmented the Spain synthetic biology market based on ngs technology, pcr technology, genome editing technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
The Spanish National Research Council (CSIC) is one of the biggest research organizations in the country. SynBio4Flav is conducted by Spanish National Research Council of the National Centre for Biotechnology (CNB), which is one of the largest research facilities in public domain in the country.
In SynBio4Flav, Systems and Synthetic Biology group of the Department of Biology and Bioengineering represents Chalmers. This group is engaged in life sciences research and is one of the leading groups in metabolic engineering, systems biology, and industrial biotechnology of Saccharomyces cerevisiae.
Furthermore, the Centre for Genomic Regulation (CRG) is continuously working in biomedical research. It is a nonprofit foundation funded by the Catalan government. The medical genomics program acts as an innovative hub for CRG’s efforts to understand human disorders.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain synthetic biology market , including forecasts for subscribers. This country databook contains high-level insights into Spain synthetic biology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account